Bioengineering

eCovSens-Ultrasensitive Novel In-House Built Printed Circuit Board Based Electrochemical Device for Rapid Detection of nCovid-19 antigen, a spike protein domain 1 of SARS-CoV-2

1. Subhasis Mahari
2. Akanksha Roberts
3. Deepshikha Shahdeo
4. Sonu Gandhi

Reviewed by ScreenIT

Treating Influenza and SARS-CoV-2 via mRNA-encoded Cas13a

1. Emmeline L. Blanchard
2. Daryll Vanover
3. Swapnil Subhash Bawage
4. Pooja Munnilal Tiwari
5. Laura Rotolo
6. Jared Beyersdorf
7. Hannah E. Peck
8. Nicholas C Bruno
9. Robert Hincapie
10. M.G. Finn
11. Frank Michel
12. Eric R. Lafontaine
13. Robert J. Hogan
14. Chiara Zurla
15. Philip J. Santangelo

Reviewed by ScreenIT

Rapid and quantitative detection of COVID-19 markers in micro-liter sized samples

1. Xiaotian Tan
2. Cory Lin
3. Jie Zhang
4. Maung Kyaw Khaing Oo
5. Xudong Fan

Reviewed by ScreenIT

Supramolecular Organization Predicts Protein Nanoparticle Delivery to Neutrophils for Acute Lung Inflammation Diagnosis and Treatment

1. Jacob W. Myerson
2. Priyal N. Patel
3. Nahal Habibi
4. Landis R. Walsh
5. Yi-Wei Lee
6. David C. Luther
7. Laura T. Ferguson
8. Michael H. Zaleski
9. Marco E. Zamora
10. Oscar A. Marcos-Contreras
11. Patrick M. Glassman
12. Ian Johnston
13. Elizabeth D. Hood
14. Tea Shuvaeva
15. Jason V. Gregory
16. Raisa Y. Kiseleva
17. Jia Nong
18. Kathryn M. Rubey
19. Colin F. Greineder
20. Samir Mitragotri
21. George S. Worthen
22. Vincent M. Rotello
23. Joerg Lahann
24. Vladimir R. Muzykantov
25. Jacob S. Brenner

Reviewed by ScreenIT

Leveraging mRNAs sequences to express SARS-CoV-2 antigens in vivo

1. Chunxi Zeng
2. Xucheng Hou
3. Jingyue Yan
4. Chengxiang Zhang
5. Wenqing Li
6. Weiyu Zhao
7. Shi Du
8. Yizhou Dong

Reviewed by ScreenIT

Investigation of ACE2 N-terminal fragments binding to SARS-CoV-2 Spike RBD

1. G. Zhang
2. S. Pomplun
3. A. R. Loftis
4. X. Tan
5. A. Loas
6. B. L. Pentelute

Reviewed by ScreenIT

Development of CRISPR as a prophylactic strategy to combat novel coronavirus and influenza

1. Timothy R. Abbott
2. Girija Dhamdhere
3. Yanxia Liu
4. Xueqiu Lin
5. Laine Goudy
6. Leiping Zeng
7. Augustine Chemparathy
8. Stephen Chmura
9. Nicholas S. Heaton
10. Robert Debs
11. Tara Pande
12. Drew Endy
13. Marie La Russa
14. David B. Lewis
15. Lei S. Qi

Reviewed by ScreenIT

Potent neutralization of 2019 novel coronavirus by recombinant ACE2-Ig

1. Changhai Lei
2. Wenyan Fu
3. Kewen Qian
4. Tian Li
5. Sheng Zhang
6. Min Ding
7. Shi Hu

Reviewed by ScreenIT

Development and biophysical characterization of a humanized FSH–blocking monoclonal antibody therapeutic formulated at an ultra-high concentration

1. Satish Rojekar
2. Anusha R Pallapati
3. Judit Gimenez-Roig
4. Funda Korkmaz
5. Farhath Sultana
6. Damini Sant
7. Clement M Haeck
8. Anne Macdonald
9. Se-Min Kim
10. Clifford J Rosen
11. Orly Barak
12. Marcia Meseck
13. John Caminis
14. Daria Lizneva
15. Tony Yuen
16. Mone Zaidi

• Curated by eLife

  eLife assessment

  This development of a highly concentrated and potentially clinically valuable antibody formulation for MS-Hu6, a first-in-class FSH-blocking humanized antibody is of potential translational importance in the management of osteoporosis, obesity, and Alzheimer's disease. The meticulous methodology is thorough and compelling in its range of techniques examining the stability and physiochemical properties of the formulated MS-Hu6.

Reviewed by eLife

RaMALDI: Enabling simultaneous Raman and MALDI imaging of the same tissue section

1. Ethan Yang
2. Jeong Hee Kim
3. Caitlin M. Tressler
4. Xinyi Elaine Shen
5. Dalton R. Brown
6. Cole C. Johnson
7. Tae-Hun Hahm
8. Ishan Barman
9. Kristine Glunde

Reviewed by PREreview, Arcadia Science